The Cigna Group
Price
OptionsOpen the Sheet →FilingsNewest: Form 10-Q, quarterly reportNov 5 →InsidersNo open-market buys. 4 insiders sold $66.8M, 18 of 19 sales on a 10b5-1 plan.→HoldersBlackRock 5.8%Vanguard 4.2%State Street 3.1%→PeersClosest companies: ELV, CVS, CNC→
From the filings
Figures
- Revenue
- $286.3Blast 12 months
- Net income
- $6.03Blast 12 months
- Operating cash flow
- $10.28Blast 12 months
- Cash and equivalents
- $6.19Bat the last balance sheet
- Total debt
- $31.14Bat the last balance sheet
- Shares outstanding
- 407.0M shareson issue
Filings, newest first
- Nov 510-QQuarterly report
- Nov 58-KResults of operations
- Oct 98-KDirector or officer change
- Sep 308-KRegulation FD disclosure
- Sep 84Insider trade
- Jul 3010-QQuarterly report
- Jul 308-KResults of operations
- Jun 164Insider trade
- May 138-KRegulation FD disclosure
- Apr 3010-QQuarterly report
- Feb 2610-KAnnual report